Coronavirus vaccine developer CureVac raises $213.3 million in U.S....

Compartió un vínculo

2020-08-14 12:42:04 -

Bill's latest investment https://finance.yahoo.com/news/coronavirus-vaccine-developer-curevac-raises-104458131.html

FINANCE.YAHOO.COM

Coronavirus vaccine developer CureVac raises $213.3 million in U.S. IPO

The German biotechnology firm, backed by Microsoft Corp founder and billionaire Bill Gates, sold 13.33 million shares at $16 apiece, the top end of its indicated price range of between $14 and $16 per share. CureVac is researching how to use messenger RNA to treat a series of diseases, including the

0 Commentarios 0 Acciones 416 Views